BridgeMD
New treatment option for Prehypertension
Official title Smartwatch-based Intervention for Cardiovascular Health (SWITCH)
ClinicalTrials.gov ID: NCT07372729
What this study is testing
- What it's testing
- This study aims to employ a cluster randomized controlled trial to evaluate the effectiveness of an mHealth-Based Multi-faceted Cardiovascular Health Intervention Model among Overweight/Obese Individuals with Cardiometabolic Preconditions, thereby providing theoretical foundations and practical guidance for the prevention and management of this population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Age \>= 18 years, no gender restriction;
- Overweight and obesity: Body Mass Index (BMI) 24.0-32.4 kg/m\^2, or waist circumference \>= 90 cm for males and \>= 85 cm for females;
- Presence of at least one metabolic high-risk state among prehypertension, prediabetes, or borderline elevated blood lipids, and without a diagnosis...
You likely can't join if
- Secondary obesity diagnosed by doctors in secondary or higher-level medical institutions;
- Cardiovascular and cerebrovascular diseases, including myocardial infarction, stroke, heart failure, arrhythmia; or having received coronary...
- Diseases seriously affecting survival, such as malignant tumors, AIDS, hepatic and renal failure;
- Pregnancy, lactation period, or women who may become pregnant within one year;
- History of severe neuropsychiatric diseases with potential cognitive or communication impairments, such as dementia, Alzheimer's disease, Parkinson's...
- Individuals with limited daily mobility;
See the full eligibility criteria
- Age \>= 18 years, no gender restriction;
- Overweight and obesity: Body Mass Index (BMI) 24.0-32.4 kg/m\^2, or waist circumference \>= 90 cm for males and \>= 85 cm for females;
- Presence of at least one metabolic high-risk state among prehypertension, prediabetes, or borderline elevated blood lipids, and without a diagnosis of hypertension, diabetes mellitus, or dyslipidemia: (1)...
- Secondary obesity diagnosed by doctors in secondary or higher-level medical institutions;
- Cardiovascular and cerebrovascular diseases, including myocardial infarction, stroke, heart failure, arrhythmia; or having received coronary intervention therapy, cardiac surgery, etc.; or with a 10-year high risk of...
- Diseases seriously affecting survival, such as malignant tumors, AIDS, hepatic and renal failure;
- Pregnancy, lactation period, or women who may become pregnant within one year;
- History of severe neuropsychiatric diseases with potential cognitive or communication impairments, such as dementia, Alzheimer's disease, Parkinson's syndrome;
- Individuals with limited daily mobility;
- Individuals undergoing or planning to receive weight loss through surgery, medication, or other methods;
- Currently participating in other lifestyle intervention-related trials.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Cangzhou, Hebei, China
- Yuhuan, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Cangzhou, Hebei, China; Yuhuan, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.